ExL Pharma’s 4th Proactive GCP Compliance conference, taking place April 10-12, 2013 at the Washington Plaza Hotel in Washington DC, continues to act as the only annual forum for both senior-level clinical quality and clinical operations executives to gather, learn and discuss practical strategies to achieve and maintain global GCP compliance. Join us in April to learn how to build quality risk management approaches into your clinical operations to ensure quality research, GCP compliance and patient safety.

“The conference was very well organized and very useful. I came away with a great number of additional aspects to consider and implement, and a confirmation of my belief that being proactive is the best way to go when it comes to GCP.” - Peter Langecker, CEO, Oxigene
“Exceeded expectations. Excellent conference with excellent speakers. All of us learned a lot and conferences like these are what improve the drug development process.”
- Munish Mehra, PhD, Managing Director, Global Drug Development Experts
“A fruitful conference with many very relevant topics on the agenda.”
- Lisbeth Bonefeld, Senior GCP Advisor Specialist, Novo Nordisk
Audience Profile from the over 130 Participants at the 2012 Annual Meeting


C-Level, Vice President, Director & Manager level executives from the following departments at Pharma/Biotech/Medical Device companies, CROs and other clinical trial service providers:
This conference is also relevant to clinical QA, compliance and operations professionals from: